Imidazo[2,1-b]thiazoles, imidazo[2,1-b]imidazoles and Pyrrolo[1,2-c]imidazoles. synthesis, structure and evaluation of benzodiazepine receptor binding
Corresponding Author
K. Kieć-Kononowicz
Jagiellonian University, Medical College, Department of Chemical Technology of Drugs, Medyczna 9, P1 30-688 Kraków, Poland
Jagiellonian University, Medical College, Department of Chemical Technology of Drugs, Medyczna 9, P1 30-688 Kraków, PolandSearch for more papers by this authorJ. Handzlik
Jagiellonian University, Medical College, Department of Chemical Technology of Drugs, Medyczna 9, P1 30-688 Kraków, Poland
Search for more papers by this authorD. Lazewska
Jagiellonian University, Medical College, Department of Chemical Technology of Drugs, Medyczna 9, P1 30-688 Kraków, Poland
Search for more papers by this authorE. Pȩkala
Jagiellonian University, Medical College, Department of Chemical Technology of Drugs, Medyczna 9, P1 30-688 Kraków, Poland
Search for more papers by this authorC. E. Müller
Pharmaceutical Institute Poppelsdorf, University of Bonn, Kreuzbergweg 26, D-53115 Bonn, Germany
Search for more papers by this authorJ. Karolak-Wojciechowska
Institute of General and Ecological Chemistry, Technical University, Zwirki 36, P1 90-924 Lódź, Poland
Search for more papers by this authorCorresponding Author
K. Kieć-Kononowicz
Jagiellonian University, Medical College, Department of Chemical Technology of Drugs, Medyczna 9, P1 30-688 Kraków, Poland
Jagiellonian University, Medical College, Department of Chemical Technology of Drugs, Medyczna 9, P1 30-688 Kraków, PolandSearch for more papers by this authorJ. Handzlik
Jagiellonian University, Medical College, Department of Chemical Technology of Drugs, Medyczna 9, P1 30-688 Kraków, Poland
Search for more papers by this authorD. Lazewska
Jagiellonian University, Medical College, Department of Chemical Technology of Drugs, Medyczna 9, P1 30-688 Kraków, Poland
Search for more papers by this authorE. Pȩkala
Jagiellonian University, Medical College, Department of Chemical Technology of Drugs, Medyczna 9, P1 30-688 Kraków, Poland
Search for more papers by this authorC. E. Müller
Pharmaceutical Institute Poppelsdorf, University of Bonn, Kreuzbergweg 26, D-53115 Bonn, Germany
Search for more papers by this authorJ. Karolak-Wojciechowska
Institute of General and Ecological Chemistry, Technical University, Zwirki 36, P1 90-924 Lódź, Poland
Search for more papers by this authorAbstract
As a continuation of our studies on bicyclic heterocycles with benzodiazepine receptor affinity, derivatives with a 5:5 bicyclic skeleton, namely imidazo[2,1-b]thiazoles, imidazo[2,1-b]imidazoles and pyrrolo[1,2-c]imidazoles were prepared. The compounds possessed an aromatic substituent with different spatial arrangement and distance to the bicyclic skeleton. X-ray structure analysis was performed for Z-2-(4-chlorobenzylidene)-5,5-diphenyl-2,3,5,6-tetrahydroimidazo[2,1-b]imidazoline-3,6-dione (6a) and 5-amino-6-cyano-7-phenyl-1-oxo-3-thioxo-2,3-dihydro-1H-pyrrolo[1,2-c]imidazole (20a). In contrast to the previously described arylideneimidazo[2,1-b]thiazepinones the smaller heterocyclic ring systems investigated in this study were devoid of meaningful benzodiazepine receptor affinity as well as anti-convulsant activity.
References and Notes
- 1 U. Geis, K. Kieć-Kononowicz and C. E. Müller, Sci. Pharm., 64, 383 (1996).
- 2 K. Kieć-Kononowicz, J. Karolak-Wojciechowska, C. E. Müller, U. Geis, W. Ksißžk and E. Szymańska, J. Heterocyclic Chem., 36, 257 (1999).
- 3 K. Kieć-Kononowicz J. Karolak-Wojciechowska, C. E. Müller, E. Pȩkala and E. Szymańska, Eur. J. Med. Chem., 36, 407 (2001).
- 4 M. Chebib and G. A. R. Johnston, J. Med. Chem., 43, 1427 (2000).
- 5 Q. Huang, X. He, C. Ma, R. Liu, S. Yu, C. A. Dayer, G. R. Wenger, R. McKernan and J. M. Cook, J. Med. Chem., 43, 71 (2000).
- 6 S. Z. Langer and S. Arbilla, Pharmacol. Biochem. Behav., 29, 763 (1988).
- 7 G. Dorey, L. Dubois, L. Prado de Carvalho P. Potier and R. H. Dodd, J. Med. Chem., 38, 189 (1995).
- 8 E. J. Jacobsen, R. E. TenBrink, L. S. Stelzer, K. L. Belonga, D. B. Carter, H. K. Im, W. B. Im, V. H. Sethy, A. H. Tang, P. F. Von Voigtlander and J. D. Petke, J. Med. Chem., 39, 158 (1996).
- 9 G. Primofiore, F. Da Settimo, S. Taliani, A. M. Marini, C. La Motta, E. Novellino, G. Greco, M. Gesi, L. Trincavelli and C. Martini, J. Med. Chem., 43, 96 (2000).
- 10 C.-G. Wang, T. Langer, P. G. Kamath, Z.-Q. Gu, P. Skolnick and R. I. Fryer, J. Med. Chem., 38, 950 (1995).
- 11 W. Zhang, K. F. Koehler, P. Zhang, and J. M. Cook, Drug. Des. Discov., 12, 193 (1995).
- 12 A. Mrozek, J. Karolak-Wojciechowska, K. Kieć-Kononowicz, J. Mol. Str. in preparation.
- 13 J. Karolak-Wojciechowska, M. Mikołajczyk, A. Zatorski, A. Zejc and K. Kieć-Kononowicz, Tetrahedron, 41, 4593 (1985).
- 14 J. Karolak-Wojciechowska and K. Kieć-Kononowicz, J. Crystallogr. Spectrosc. Res., 17, 485 (1987).
- 15 K. Kieć-Kononowicz and J. Karolak-Wojciechowska, Arch. Pharm. (Weinheim), 328, 119 (1995).
- 16 J. Karolak-Wojciechowska, W. Kwiatkowski and K. Kieć-Kononowicz, Acta Cryst., C45, 1467 (1989).
- 17 W. Kwiatkowski, J. Karolak-Wojciechowska and K. Kieć-Kononowicz, Acta Cryst., C47, 1256 (1991).
- 18 J. Karolak-Wojciechowska and K. Kieć-Kononowicz, Acta Cryst., C47, 2371 (1991).
- 19 K. Kieć-Kononowicz and J. Karolak-Wojciechowska, Phosphorus, Sulfur and Silicon, 73, 235 (1992).
- 20 J. Karolak-Wojciechowska, A. Mrozek and K. Kieć-Kononowicz, J. Mol. Str., 516, 113 (2000).
- 21 H. A. F. Daboun, S. E. Abdou, M. M. Hussein and M. H. Elnagdi, Synthesis, 502 (1982).
- 22 R. L. Krall, J. K. Penry, B. G. White, H. J. Kupferberg, E. A. Swinyard, Epilepsia, 19, 400 (1978).
- 23 R. J. Porter, J. J. Cereghino, G. D. Gladding, B. J. Hessie, H. J. Kupferberg, B. Scoville, B. G. White, Cleveland Clin. Q., 51, 293 (1984).
- 24 PALLAS for Windows 1.2, CompuDrug Chemistry Ltd., 1995.
- 25 MOPAC 6.0, QCPE No. 455; Department of Chemistry, Indiana University, Bloomington, IN 47405, 1990.
- 26 A. F. A. Shalaby, H. A. Daboun and S. S. M. Z. Boghdadi, Z. Naturforsch., 29B, 99 (1974).
- 27 K. Kieć-Kononowicz, J. Karolak-Wojciechowska, A. Mrozek and M. Poseł, Arch. Pharm. (Weinheim), 328, 517 (1995).
- 28 K. Kieć-Kononowicz, J. Karolak-Wojciechowska and J. Handzlik, Acta Polon.-Drug Res., 55, 381 (1998).
- 29
G. M. Sheldrick,
Acta Cryst.,
A 46,
467
(1990).
10.1107/S0108767390000277 Google Scholar
- 30 G. M. Sheldrick, SHELXL-93. Program for the Refinement of the Crystal Structures. University of Göttingen, Germany (1993).
- 31 Further details of the crystal structure 6a and 20a including structure factors, anisotropic displacement parameters and H-atom coordinatea are available on request from one of the authors [J. K.-W.].